STOCK TITAN

ViewRay to Present at the 39th Annual J.P. Morgan Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

ViewRay, Inc. (NASDAQ: VRAY) will participate in the 39th Annual J.P. Morgan Healthcare Conference. CEO Scott Drake is scheduled to present on January 14, 2021, at 10:50 a.m. Eastern Time. An audio webcast of the presentation will be accessible on the company's investor website, with a replay available for 14 days afterward. ViewRay specializes in the MRIdian® radiation therapy system, which features a high-definition MR imaging system specifically designed for advanced radiation oncology challenges such as beam distortion and skin toxicity.

Positive
  • None.
Negative
  • None.

CLEVELAND, Dec. 23, 2020 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) today announced its participation in the 39th Annual J.P. Morgan Healthcare Conference. Scott Drake, President and CEO, is scheduled to present at 10:50 a.m. Eastern Time on Thursday, January 14, 2021.

An audio webcast of the Company's presentation will be available on the "Financial Events and Webinars" portion of ViewRay's investor website at https://investors.viewray.com/events-and-presentations/upcoming-events. A replay of the webcast will be available for 14 days after the date of the presentation.

About ViewRay
ViewRay, Inc. (Nasdaq: VRAY), designs, manufactures, and markets the MRIdian® radiation therapy system. MRIdian is built upon a proprietary high-definition MR imaging system designed from the ground up to address the unique challenges and clinical workflow for advanced radiation oncology. Unlike MR systems used in diagnostic radiology, MRIdian's high-definition MR was purpose built to address specific challenges, including beam distortion, skin toxicity, and other concerns that potentially may arise when high magnetic fields interact with radiation beams. ViewRay and MRIdian are registered trademarks of ViewRay, Inc.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/viewray-to-present-at-the-39th-annual-jp-morgan-healthcare-conference-301197863.html

SOURCE ViewRay, Inc.

FAQ

When will ViewRay present at the J.P. Morgan Healthcare Conference?

ViewRay will present at the J.P. Morgan Healthcare Conference on January 14, 2021, at 10:50 a.m. Eastern Time.

Where can I watch the ViewRay presentation?

The ViewRay presentation can be watched via an audio webcast available on their investor website.

How long will the ViewRay conference presentation be available for replay?

The replay of the ViewRay conference presentation will be available for 14 days after the event.

What is the focus of ViewRay's MRIdian system?

The MRIdian system is designed to address specific challenges in advanced radiation oncology, including beam distortion and skin toxicity.

What is the stock symbol for ViewRay?

The stock symbol for ViewRay is VRAY.

ViewRay Inc.

NASDAQ:VRAY

VRAY Rankings

VRAY Latest News

VRAY Stock Data

Surgical and Medical Instrument Manufacturing
Manufacturing
Link
US
Oakwood Village